Showing results (151-160 of 421) with videos related to
Sort By:
Pageof 43
The Journal of Urology|March 28, 2022
Absolute Prostate Specific Antigen after 6 Months of Androgen Deprivation Therapy Is a Predictor of Overall and Cancer-Specific Mortality in Men with Hormone-Sensitive Prostate CancerFurkan Dursun, Chen-Pin Wang, Daniel MacCarthy, et al.The Journal of Urology|April 18, 2007
Finasteride improves the sensitivity of digital rectal examination for prostate cancer detectionIan M Thompson, Catherine M Tangen, Phyllis J Goodman, et al.The Journal of Urology|November 16, 2010
Prospective evaluation of operating characteristics of prostate cancer detection biomarkersYuanyuan Liang, Donna P Ankerst, Norma S Ketchum, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 21, 2010
Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of menJoke Beuten, Jonathan A L Gelfond, Jennifer L Franke, et al.The Journal of Urology|December 18, 2007
Association of polymorphisms in TGFB1 and prostate cancer prognosisTimothy C Brand, Carlos Bermejo, Edith Canby-Hagino, et al.European Urology|July 16, 2018
Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate CancerMichael A Liss, James Robert White, Martin Goros, et al.Clinical Genitourinary Cancer|March 9, 2022
Hereditary Cancer Gene Variants in Hispanic Men With a Personal or Family History of Prostate CancerChethan Ramamurthy, Eric W Stutz, Martin Goros, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 22, 2011
Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention TrialAlan R Kristal, Cathee Till, Elizabeth A Platz, et al.American Journal of Epidemiology|February 10, 2010
Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trialJeannette M Schenk, Alan R Kristal, Marian L Neuhouser, et al.JAMA Oncology|March 31, 2017
Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone InductionThomas W Flaig, Melissa Plets, Maha H A Hussain, et al.Pageof 43